Transcriptional modulation of calcium-permeable AMPA receptor subunits in glioblastoma by MEK-ERK1/2 inhibitors and their role in invasion.
Glioblastoma is the most common primary brain tumor. Glioblastoma cells secrete a significant amount of glutamate, which serve as a potential growth factor in glioma pathobiology, through their specific receptor subtypes, including α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR). Glioblastoma express AMPAR subunits; however, its regulation and activation with downstream intracellular signaling are not well understood. Phosphorylated-extracellular signaling-regulated kinase (ERK)1/2 is known to regulate the ionotropic glutamate receptors in cortical neurons. The mitogen-activated protein kinase cascade is frequently activated in several tumors, including glioma. Nonetheless, the association of ERK signaling with AMPA receptor subunits in glioblastoma is undetermined. Here, we demonstrated potential role of AMPAR in invasion, and the modulation of AMPA receptor subunits at transcript level by ERK signaling in glioblastoma cells. Inhibition of ERK signaling specifically down-regulated the expression of calcium-permeable AMPAR subunits, GluA1 and GluA4, and up-regulated calcium-impermeable AMPAR subunit GluA2 implying differential regulation of the expression of calcium-permeable AMPA receptor subunits of glioblastoma. Concomitantly, it significantly decreased the invasion of U87MG cells. Corollary, these findings suggest that the AMPAR enhances invasion of glioblastoma, and ERK signaling modulates the differential expression of calcium permeable AMPA receptor phenotype that might play crucial role in the invasive propensity of glioblastoma cells. This article is protected by copyright. All rights reserved.